Alpha DNA Investment Management’s XPO XPO Stock Holding History

Alpha DNA Investment Management’s Portfolio XPO Stock Details XPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-69	Closed	-$2K	–	676
2021 Q1	$2K	Buy	+69	New	+$2.86K	﹤0.01%	592

Other funds holding XPO

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Alpha DNA Investment Management's XPO Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of XPO (XPO) in Q2 2021, closing a stake of 69 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in XPO in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 558 funds tracked by Wall St. Rank hold XPO as of Q2 2021.

Alpha DNA Investment Management reported no remaining XPO position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 69 XPO shares in Q2 2021, an estimated $2K.
Alpha DNA Investment Management first reported a position in XPO in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's XPO position peaked at $2K in Q1 2021.
558 funds tracked by Wall St. Rank held XPO as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.